Hormones and Cancer Research Unit, Department of Medicine, Royal Victoria Hospital, McGill University, 687 Pine Avenue West, H3A 1A1, Montreal, Quebec, Canada.
Adv Exp Med Biol. 2009;668:69-78. doi: 10.1007/978-1-4419-1664-8_7.
Pituitary adenomas are common monoclonal neoplasms accounting for approximately one-fifth of primary intracranial tumors. Prolactin-secreting pituitary adenomas (prolactinomas) are the most common form of pituitary tumors in humans. They are associated with excessive release of the hormone prolactin and increased tumor growth, giving rise to severe endocrine disorders and serious clinical concerns for the patients. Recent studies indicated that the activin/TGF-beta family of growth factors plays a prominent role in regulating pituitary tumor growth and prolactin secretion from anterior pituitary lactotrope cells. Furthermore, these studies highlighted the tumor suppressor menin and the protein Smads as central regulators of these biological processes in the pituitary. Alterations in the activin/TGF-beta downstream signaling pathways are critical steps towards tumor formation and progression. This chapter will review the role and intracellular molecular mechanisms of action by which activin, TGF-beta, Smads and menin act in concert to prevent pituitary tumor cell growth and control hormonal synthesis by the anterior pituitary.
垂体腺瘤是常见的单克隆肿瘤,约占原发性颅内肿瘤的五分之一。催乳素分泌性垂体腺瘤(催乳素瘤)是人类最常见的垂体肿瘤形式。它们与激素催乳素的过度释放和肿瘤生长增加有关,导致严重的内分泌紊乱和患者的严重临床问题。最近的研究表明,激活素/TGF-β家族的生长因子在调节垂体瘤生长和催乳素分泌方面起着重要作用。此外,这些研究强调了肿瘤抑制因子门宁和 Smads 蛋白作为垂体中这些生物学过程的中央调节剂。激活素/TGF-β下游信号通路的改变是肿瘤形成和进展的关键步骤。本章将综述激活素、TGF-β、Smads 和门宁协同作用以防止垂体瘤细胞生长和控制垂体前叶激素合成的作用及其细胞内分子机制。